4. Has a new hematologic disorder been diagnosed?
aFactors influencing long-term risk include: integration of the vector into
the genome; vector persistence without integration; and transgene-specific effects
Acknowledgment
I would like to thank Valder Arruda, MD, PhD, for his review of the
manuscript
Further Readings
Hacein-Bey-Abina S et al: LMO2-associated clonal T cell proliferation in
two patients after gene therapy for SCID-XI. Science 302:415, 2003 [PMID:
Bạn đang xem 4. - CHAPTER 065 GENE THERAPY IN CLINICAL MEDICINE PART 5 PPT